New At Hepatitis C Online: Vosevi and Mavyret

Hepatitis C Online is a free educational, web-based service that functions as a comprehensive resource for diagnosing, monitoring and managing the Hepatitis C virus infection. The service is produced at the University of Washington, through a partnership with the International Antiviral Society-USA, and funded by a grant from the Center for Disease Control and Prevention.

Although Hepatitis C Online is aimed at clinicians, a wealth of information is provided for people living with HCV as well. This interactive site offers easy to follow modules about the natural history of HCV, staging liver fibrosis, managing cirrhosis and treating the virus, click here to browse materials.

Updates At Hepatitis C Online

Information on Gilead's newly FDA approved Vosevi and AbbVie's Mavyret  was recently added, however, make sure to check the website in the future for additional updates. The clinical trial data is not new information, but now its easier to review.

Here are a few links to get you started:

Summary

Start Here: Sofosbuvir-Velpatasvir-Voxilaprevir (Vosevi)

Links

View clinical trial data in either slide decks, in your browser or download PDF.

Key Drug Interactions

For complete information on sofosbuvir-velpatasvir-voxilaprevir-related drug interactions, see the Drug Interactions section in the Sofosbuvir-Velpatasvir-Voxilaprevir (Vosevi) Prescribing Information.

Begin here.....

Summary

Start Here: Glecaprevir-Pibrentasvir (Mavyret)

Prescribing information: last updated August 4, 2017 (provided by AbbVie Inc.)

Data: All Clinical Trials

Slide Deck 

Begin here.........